Our results revealed that the MIAT rs2331291 T allelic frequency showed a significant increase in CIS cases compared to healthy controls (32.5% vs. 8.8%) and could be a risk factor for CIS compared with the C allelic frequency. This evidence concerns the gene MIAT and in situ carcinoma.